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ABSTRACT 15 
  16 
Background: 17 
 18 
The purpose of this study was to assess the effect of demineralised bone matrix 19 
(DBM) on rotator cuff tendon-bone healing. The hypothesis was that compared to a 20 
commercially-available dermal matrix scaffold, DBM would result in a higher bone 21 
mineral density and regenerate a morphologically superior enthesis, in a rat model of 22 
chronic rotator cuff degeneration. 23 
  24 
Methods: 25 
 26 
Eighteen female Wistar rats underwent unilateral detachment of the supraspinatus 27 
tendon. Three weeks later, tendon repair was carried out in animals randomized into 28 
three groups: Group 1 were repaired with DBM (n = 6); Group 2 received 29 
augmentation with the dermal scaffold (n = 6); and Group 3 (controls) underwent 30 
non-augmented tendon-bone repair (n = 6). Specimens were retrieved at six weeks 31 
postoperatively for histological analysis and evaluation of bone mineral density. 32 
 33 
Results: 34 
 35 
No failures of tendon-bone healing were noted throughout the study. All groups 36 
demonstrated closure of the tendon-bone gap with a fibrocartilaginous interface. 37 
Dermal collagen specimens exhibited a disorganized structure with significantly more 38 
abnormal collagen fiber arrangement and cellularity than the DBM-based repairs. 39 
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Non-augmented repairs exhibited a significantly higher bone mineral density than 40 
DBM and the dermal collagen specimens, and were not significantly different to non-41 
operated control limbs.  42 
 43 
Conclusion:  44 
 45 
The application of DBM to a rat model of chronic rotator cuff degeneration did not 46 
improve the composition of the healing enthesis compared to non-augmented controls 47 
and a commercially-available scaffold. However, perhaps the most important finding 48 
of this study was that the control group demonstrated a similar outcome to augmented 49 
repairs.  50 
 51 
Level of evidence: Basic science study.  52 
  53 
Keywords: animal model; enthesis healing; rotator cuff; scaffold; shoulder; tendon  54 
bone; tissue engineering55 
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INTRODUCTION 56 
 57 
Tendon-bone healing is an important factor affecting the outcome of rotator cuff 58 
repair. 6 Anatomical reattachment of the rotator cuff to its bony insertion is crucial, 59 
but tendon degeneration and poor bone quality at the enthesis compromises the 60 
quality, healing capacity, and durability of the performed repair. 14 In order to absorb 61 
the energy of loading between tendon and bone, the native enthesis comprises a 62 
natural gradation of four histological zones (tendon, demineralized fibrocartilage, 63 
mineralized fibrocartilage, and bone). 18 Following injury, this is replaced by a weak 64 
fibrovascular bridge with inferior biomechanical properties. 4; 7; 10 Osteopenia at the 65 
greater tuberosity often accompanies this change in structure, leading to a reduction in 66 
the pullout strength of suture anchors. 1; 3; 15; 21  67 
  68 
Demineralised bone matrix (DBM) is an osteoinductive agent that consists of a 69 
collagen scaffold containing several growth factors. It has been demonstrated in vivo 70 
to regenerate a fibrocartilaginous enthesis capable of resisting physiological forces, 71 
but has not been investigated in a degenerative model of tendon-bone healing. 12; 16; 17 72 
The purpose of this study was to assess the effect of DBM on regeneration of an 73 
enthesis following repair of a degenerative rotator cuff tear. We compared DBM with 74 
another commercially available augmentation product with clinically-investigated 75 
profiles of activity (GraftJacket [Wright Medical Technology, Inc., Arlington, TN 76 
(Tennessee)]). GraftJacket (Wright Medical Technology, Inc., Arlington, TN) is 77 
obtained from donated human cadaveric dermal tissue processed to remove its cellular 78 
components whilst retaining its extra-cellular matrix. Its acellularity has the advantage 79 
of not causing a host inflammatory reaction and it has been safely used in rats to 80 
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enhance healing of a large acute rotator cuff tear. 8 The hypothesis was that 81 
augmentation with DBM will result in a higher bone mineral density in the recipient 82 
footprint and regenerate a morphologically superior enthesis characterized by greater 83 
fibrocartilage formation and improved collagen fiber organization in a rat model of 84 
chronic rotator cuff degeneration when compared to accellular human dermal matrix, 85 
after repair of a tendon tear.        86 
      87 
 88 
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MATERIALS AND METHODS 89 
 90 
Study Design  91 
 92 
In this basic science study, all animal work was conducted in accordance with a 93 
Project License protocol accepted under the UK Home Office Animals (Scientific 94 
Procedures) Act 1986. Eighteen female Wistar rats underwent unilateral detachment 95 
of the supraspinatus tendon. Previously published data was used to calculate the 96 
number of animals (n = 6) required to generate a power of 0.8 with significance at the 97 
0.05 level. 16 Three weeks later, tendon repair was carried out in animals randomized 98 
into three groups : Group 1 received augmentation of the repair with cortical allogenic 99 
DBM (n = 6); Group 2 received augmentation with non-meshed, ultra-thick accellular 100 
human dermal matrix ((n = 6) (GraftJacket, Wright Medical Technology, Inc., 101 
Arlington, TN;  average 1.4mm thickness); and Group 3 underwent direct tendon-102 
bone repair without augmentation (n = 6). One surgeon carried out all procedures 103 
using a standard technique. Animals were allowed to mobilise freely after surgery. 104 
Specimens were retrieved at six weeks postoperatively for histological analysis and 105 
peripheral quantitative computer tomography (pQCT) to evaluate bone mineral 106 
density (BMD) at the reattachment footprint of the tendon, reversal of degenerative 107 
changes within the tendon, and histological remodeling of the implanted 108 
augmentation material.   109 
 110 
DBM Manufacture 111 
 112 
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DBM derived from cortical bone was manufactured according to Urist’s protocol, 113 
with modifications. 20 The tibiae of skeletally mature female Wistar rats were 114 
harvested immediately after euthanasia; all soft tissues and periosteum were stripped 115 
from the bone surface. Bones measuring approximately 30 mm length by 3 mm width 116 
were demineralized in 0.6 N HCL at room temperature. Demineralization was 117 
confirmed by taking radiographs (300 seconds, 30 kV, Faxitron Corporation, Illinois, 118 
USA). This was followed by washing in phosphate-buffered saline until the pH was 119 
7.4 +/- 0.1. Samples were stored at -20 ̊ C for two hours and transferred to a 120 
lyophiliser (Edwards Girovac Ltd, Crawley, West Sussex, UK) for three days. 121 
Specimens were then sealed in individual plastic bags, sterilised by gamma irradiation 122 
at a dose of 25 kilograys (Isotron Limited, Reading, UK), and stored at -20 ̊ C. 123 
Samples were rehydrated at the time of surgery in normal saline for 30 minutes prior 124 
to use. 125 
 126 
Surgical Technique  127 
 128 
Two surgeries were performed on each animal: full-thickness supraspinatus tendon 129 
detachment and complete tendon reattachment. Anaesthesia was induced and 130 
maintained using 2% isoflurane mixed with pure oxygen via a facemask for both 131 
procedures. The right shoulder was operated on in all cases. A 1.5 cm skin incision 132 
was made directly over the anterolateral border of the acromion. The deltoid was 133 
detached from the acromion and split caudally for 0.5 cm, in order to identify the 134 
tendon of supraspinatus. The supraspinatus tendon was completely detached from its 135 
bony insertion on the humeral head, marked with a 5’0 prolene suture (Ethicon, 136 
Johnson & Johnson Medical Ltd., Berkshire, UK) at the musculotendinous junction 137 
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(MTJ), and allowed to retract medially. Deltoid muscle, superficial fascia, and skin 138 
were closed with 5’0 Vicryl suture (Ethicon, Johnson & Johnson Medical Ltd., 139 
Berkshire, UK). Animals were allowed unrestricted cage activity and received 140 
analgesia (subcutaneous buprenorphine) every 12 hours for three days. The second 141 
surgery to reattach the tendon was undertaken three weeks after the first procedure. 142 
Prior to making the skin incision, the DBM or GraftJacket (Wright Medical 143 
Technology, Inc., Arlington, TN) was rehydrated for 30 minutes in sterile normal 144 
saline at the operating table.   145 
 146 
A 2 cm skin incision was made in line with the supraspinatus muscle belly, ending 147 
anterior to the lateral end of the clavicle. This approach was perpendicular to the 148 
incision used for tendon detachment in order to make use of a virgin anatomical plane 149 
devoid of scar tissue. The muscle belly of supraspinatus was identified and followed 150 
distally to reveal the tendon stump with the suture marker in the MTJ. Scar tissue 151 
between the tendon stump and its insertion was excised and the tendon was grasped 152 
with a double-armed 5’0 prolene using a modified Mason-Allen technique. 19 Despite 153 
traction on the tendon stump, it could not be directly brought back to the humeral 154 
head in any of the cases. The bare tendon-bone insertion footprint was decorticated 155 
using a #11 surgical blade until bleeding was seen. A custom-made dental drill was 156 
used to drill a 1 mm hole from the neck of the humerus to the bony insertion of the 157 
detached supraspinatus.  158 
 159 
The scaffold (DBM or GraftJacket) was cut into a strip 10 mm long and 3 mm wide. 160 
Each limb of the suture was passed through the scaffold to secure it in position. One 161 
suture limb was passed through the hole in the prepared tendon stump and the other 162 
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suture limb was passed through the hole on the neck of the humerus. The 163 
supraspinatus tendon-scaffold complex was attached to the insertion site, with the 164 
graft in contact with both the tendon stump proximally and decorticated bone surface 165 
distally (Figure 1). In the control group the sutures were inserted directly into the drill 166 
holes, leaving a 5 mm gap between the tendon and bone in all cases.  167 
 168 
A layered wound closure was undertaken in a similar manner to the first surgery, and 169 
the animals were permitted unrestricted cage activity. Postoperative analgesia (Intra-170 
muscular Buprenorphine 0.6 mg) was given every 12 hours for three days. 171 
 172 
Histological Assessment  173 
 174 
After euthanasia with carbon dioxide, the right shoulder was dissected and a specimen 175 
comprising the humerus with its attached supraspinatus musculotendinous unit was 176 
removed. Each sample was fixed in 10% formal saline and underwent decalcification 177 
in EDTA, ascending graded alcohol dehydration, defatting in chloroform, and 178 
embedding in paraffin. Multiple sections, 4µm thick, were cut in the coronal plane 179 
through the humerus, enthesis, and supraspinatus musculotendinous unit using a 180 
microtome. Sections were attached to glass slides and stained with hematoxylin and 181 
eosin (H&E).    182 
 183 
Two blinded observers evaluated all sections using an Olympus BH-2 light 184 
microscope (Olympus, Glasgow, UK). Tendon degeneration was assessed according 185 
to a modified Movin scale 13 and included the following variables: (1) fiber structure, 186 
(2) fiber arrangement, (3) rounding of the nuclei, (4) regional variations in cellularity, 187 
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(5) increased vascularity, and (6) hyalinization. A four-point scoring system was used: 188 
0 = normal appearance, 1 = slightly abnormal appearance, 2 = a moderately abnormal 189 
appearance, and 3 = a markedly abnormal appearance. 11 Based on this, the total score 190 
for any given slide could range from 0 (normal tendon) to 18 (the greatest level of 191 
degeneration). 192 
 193 
Maturation of the enthesis was assessed according to the scoring system developed by 194 
Ide et al 8: score 1 – the insertion had continuity without fibrous tissue or bone 195 
ingrowth, score 2 – the insertion had continuity with fibrous tissue ingrowth but no 196 
fibrocartilage cells, score 3 – the insertion had continuity with fibrous tissue ingrowth 197 
and fibrocartilage cells but no tidemark, and score 4 – the insertion had continuity 198 
with fibrous tissue ingrowth, fibrocartilage cells, and a tidemark.  199 
 200 
Measurement of Bone Mineral Density 201 
 202 
Changes in bone mineral density at the humeral head were assessed using pQCT 203 
scanning. One millimeter slices were obtained through the humeral head and 204 
supraspinatus musculotendinous unit using an XCT 2000 Bone Scanner (Stratec 205 
Medizintechnik Gmbh, Germany) with Software version 6.20. Controls were obtained 206 
from the contralateral (non-operated) shoulder in six animals subjected to the same 207 
rehabilitation conditions as the study groups. 208 
 209 
Statistical Analysis 210 
  211 
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Numerical data were analysed using SPSS software package, version 23 (SPSS Inc, 212 
an IBM Company, Chicago, Illinois). Mann Whitney U tests were used to compare 213 
data between groups. Results were considered significant at the p < 0.05 level.214 
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RESULTS 215 
 216 
All animals survived the duration of the study and none had post-operative infection. 217 
Limping was noted for the first three to five postoperative days but a normal gait 218 
pattern returned thereafter.  219 
 220 
Macroscopic Findings  221 
  222 
At the time of euthanasia there was continuity between the repaired tendon and the 223 
bone in all groups (Figure 2). No signs of infection were noted in any specimen, none 224 
of the repairs had failed, and all the sutures were intact. Remodeling of the graft 225 
material occurred to a greater extent in the DBM group, whereby the scaffold could 226 
not be discerned from other tissues in the regenerated tendon-bone interface. In 227 
contrast, accellular human dermal matrix was clearly visible at necropsy. Control 228 
group specimens demonstrated complete closure of the enthesis.    229 
 230 
Quantitative Histology 231 
 232 
Enthesis Maturation Score 233 
  234 
No significant difference was observed in the enthesis maturation score between 235 
experimental groups. However, the dermal matrix specimens exhibited a more 236 
disorganized enthesis than control and DBM groups, which were characterized by a 237 
well organised, graded structure (Figures 3 and 4). The median enthesis maturation 238 
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score was 2.5 (95% CI 1.88 to 3.46) in the controls, 3 (95% CI 2 to 4) in the DBM 239 
group, and 2.5 (95% CI 2.02 to 2.81) in the accellular human dermal matrix group.  240 
 241 
Modified Movin Score  242 
 243 
No significant difference in the modified Movin score (indicating degeneration) was 244 
demonstrated between experimental groups (Figure 5). The median modified Movin 245 
score was 7 (95% CI 5.04 to 10.62) in the controls, 6 (95% CI 3.37 to 10.47) in the 246 
DBM group, and 9.25 (95% CI 6.94 to 10.89) in the dermal matrix group.   247 
 248 
Fiber Structure   249 
 250 
All groups exhibited increased waviness and distance between collagen fibers (Figure 251 
6). The median score was 1.75 (95% CI 1.07 to 2.10) in the controls, 1.75 (95% CI 252 
0.66 to 2.83) in the DBM group, and 1.5 (95% CI 0.83 to 2.67) in the dermal matrix 253 
group. There were no significant inter-group differences. 254 
 255 
Fiber Arrangement  256 
 257 
All groups exhibited a loss of the parallel arrangement that typically characterises the 258 
fiber arrangement in tendons (Figure 6). The median score was 1.5 (95% CI 0.88 to 259 
2.46) in the controls, 1.25 (95% CI 0.84 to 2.16) in the DBM group, and 2.25 (95% CI 260 
1.90 to 2.76) in the accellular human dermal matrix group. Fiber arrangement was 261 
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significantly more abnormal in the dermal matrix group than in the DBM group (p = 262 
0.039). There were no other significant inter-group differences. 263 
 264 
Tenocyte Nuclei    265 
 266 
Rounding of nuclei (indicating persistent degeneration) was identified in all groups 267 
following tendon reattachment (Figure 7). The median score was 1.75 (95% CI 1.12 268 
to 2.55) in the controls, 1.50 (95% CI 1.03 to 1.97) in the DBM group, and 2 (95% CI 269 
1.56 to 2.10) in the dermal matrix group. There were no significant inter-group 270 
differences.   271 
 272 
Cellularity    273 
 274 
Specimens were evaluated for an increase in cellularity, indicating persistent 275 
degeneration. The median score was 1.50 (95% CI 0.97 to 2.20) in the controls, 1.25 276 
(95% CI 0.70 to 1.97) in the DBM group, and 2 (95% CI 1.69 to 2.48) in the 277 
accellular human dermal matrix group. Cellularity was significantly less in the DBM 278 
group than in the dermal matrix group (p = 0.037), but there were no other significant 279 
inter-group differences. 280 
 281 
 282 
 283 
 284 
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Vascularity  285 
 286 
Specimens were evaluated for an increase in vascularity, indicating persistent 287 
degeneration. 11 The median score was 1.50 (95% CI 0.54 to 2.12) in the controls, 288 
0.25 (95% CI -0.35 to 2.01) in the DBM group, and 1 (95% CI 0.30 to 1.53) in the 289 
accellular human dermal matrix group. There were no significant inter-group 290 
differences.   291 
  292 
Hyalinisation 293 
 294 
Hyalinisation was not observed in any of the specimens.  295 
 296 
pQCT 297 
 298 
For comparison with the operated side, control specimens were harvested from the 299 
contralateral non-operated shoulder of the animals not used in this study. In this group 300 
(n = 6), the median total bone mineral density at the supraspinatus tendon-bone 301 
insertion was 793.25 mg/ccm (95% CI 754.24 to 844.70) (Figure 8). This 302 
significantly decreased at six weeks following augmented tendon repair with DBM 303 
and accellular human dermal matrix to a median of 721.20 mg/ccm (95% CI 537.52 304 
to 771.68) (p = 0.004) and 620.55 mg/ccm (95% CI 551.01 to 733.80) (p = 0.006) 305 
respectively. Following attempted direct repair of the supraspinatus tendon to bone 306 
without the addition of an augmentation strategy, median bone mineral density at the 307 
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enthesis was 756.30 mg/ccm (95% CI 648.01 to 818.46). This was not significantly 308 
different to controls (p = 0.078).  309 
 310 
 311 
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DISCUSSION 312 
 313 
In this study, we hypothesised that: 1. DBM would regenerate a morphologically 314 
superior enthesis characterized by greater fibrocartilage formation and improved 315 
collagen fiber organisation compared to a commercially available accellular human 316 
dermal matrix scaffold (GraftJacket); 2. DBM would result in a higher bone mineral 317 
density at the footprint insertion site. However, our results do not support either 318 
hypothesis. Using a previously validated rat model of chronic rotator cuff 319 
degeneration, 2 the supraspinatus tendon was reattached to its bony insertion with 320 
interposed DBM, dermal collagen, or no augmentation (controls) and analysed after 321 
six weeks. All groups demonstrated closure of the tendon-bone gap with a 322 
fibrocartilagenous interface, but the degenerative process at this time point could not 323 
be reversed (there was a persistently high Modified Movin score in all groups). 324 
Although there was no significant difference in enthesis maturation scores at the 325 
conclusion of the study, the dermal collagen specimens exhibited a disorganized 326 
structure with significantly more abnormal collagen fiber arrangement and cellularity 327 
than the DBM repairs (indicating more severe degeneration).  328 
 329 
Bone mineral density at the enthesis was the second parameter examined because it 330 
has been shown to determine the quality and degree of tendon-bone healing, and the 331 
pullout strength of suture anchors in the clinical setting. 3; 12 Following tendon 332 
reattachment with DBM and dermal collagen, this did not recover to the baseline 333 
levels (bone mineral density at the non-operated tendon insertion site). In contrast, the 334 
non-augmented repairs exhibited a significantly higher bone mineral density than 335 
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DBM and dermal collagen specimens, and were not significantly different to control 336 
specimens.  337 
 338 
Several in vivo studies have demonstrated the ability of DBM to enhance tendon-bone 339 
healing, but not in a degenerative rotator cuff model. 9; 12; 16; 17 In the first study to 340 
examine the use of DBM at the healing enthesis, Sundar et al 16 created an acute tear 341 
in an ovine patellar tendon model and repaired it with the scaffold. Compared to 342 
controls at 12-weeks, the DBM group showed increased amounts of mineralised 343 
fibrocartilage and improved functional weight-bearing. To determine the effect of 344 
DBM on tendon healing within a bone tunnel, Kilicoglu et al 9 developed a rabbit 345 
model and retrieved specimens three, six, and nine weeks after surgery. At three 346 
weeks, a higher number of Sharpey’s fibers, slightly increased fibrocartilage 347 
formation, and new bone formation was observed in the DBM group, but this 348 
difference was not significant at later time-points. In a further study examining the 349 
healing potential of a DBM paste in a tendon-bone tunnel, Lovric et al 12 created a rat 350 
model of anterior cruciate ligament (ACL) reconstruction. No reconstitution of the 351 
fibrocartilage layer was observed in either the DBM or control groups. The main 352 
finding was a significantly greater amount of new bone formation in DBM-augmented 353 
animals associated with a significantly higher peak load to failure of the tendon-bone 354 
interface at six weeks. Similar findings were noted in an ovine model of severe tendon 355 
retraction, where DBM was used to enhance healing across a 1 cm defect. In this 356 
study, there was an improvement in functional weight bearing at successive time 357 
points and the development of a direct enthesis characterised by fibrocartilage. 17 358 
 359 
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The current study could not reproduce the results of DBM-induced tendon-bone 360 
healing observed in other animal models. Considering that the overall contact area 361 
between tendon and bone is a major determinant of healing, the limited tendon-bone 362 
surface area in a rat model does not present an environment that is as conducive to 363 
healing as large animal models and those that utilise a tendon-bone tunnel. 5 364 
Furthermore, the high shear forces from contraction of supraspinatus are distributed 365 
over a relatively small surface area and therefore may not have allowed adequate 366 
tendon healing to take place. 6 Perhaps the most important finding of this study was 367 
that the non-augmented control group demonstrated a similar histological outcome to 368 
those tendons repaired with DBM and dermal collagen, and also resulted in a bone 369 
mineral density at the tendon insertion comparable to non-operated controls. This 370 
raises considerable doubt as to the suitability of a rat model to investigate rotator cuff 371 
tendon-bone healing, because in humans spontaneous healing is thought not to occur.  372 
  373 
There are several limitations to this study. Previous work has shown that most control 374 
tendons in a rat model heal by eight weeks, making it challenging to detect 375 
differences between control and experimental groups because it is difficult to improve 376 
on a solid mass of healed scar tissue. 6 Earlier time points in the healing phase (two 377 
and four weeks) may have highlighted differences that later became non-significant 378 
between groups. Similarly, later time points (nine and 12 weeks) may have allowed 379 
greater time for the scaffolds to remodel and exert their restorative effect on tendon-380 
bone healing. Finally, biomechanical evaluation of the repair construct would have 381 
strengthened the results of this study, but due to the limited number of specimens this 382 
could not be performed.  383 
 384 
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CONCLUSION 385 
 386 
This study has highlighted the difficulty of developing a scaffold to solve the problem 387 
of rotator cuff tendon-bone healing. Although the application of DBM to a chronic 388 
rotator cuff tear does result in an enthesis comprised of fibrocartilage, this was not 389 
significantly more mature than non-augmented controls or a commercially available 390 
alternative accellular human dermal matrix scaffold.   391 
Tendon Reattachment using Demineralised Bone Matrix 
 21 
REFERENCES  392 
 393 
1. Braunstein V, Ockert B, Windolf M, Sprecher CM, Mutschler W, Imhoff A et al. 394 
Increasing pullout strength of suture anchors in osteoporotic bone using 395 
augmentation--a cadaver study. Clinical biomechanics (Bristol, Avon) 2015; 30:243-396 
7. 10.1016/j.clinbiomech.2015.02.002. 397 
2. Buchmann S, Walz L, Sandmann GH, Hoppe H, Beitzel K, Wexel G et al. Rotator 398 
cuff changes in a full thickness tear rat model: verification of the optimal time interval 399 
until reconstruction for comparison to the healing process of chronic lesions in 400 
humans. Archives of orthopaedic and trauma surgery 2011; 131:429-35. 401 
10.1007/s00402-010-1246-5. 402 
3. Cadet ER, Hsu JW, Levine WN, Bigliani LU, Ahmad CS. The relationship between 403 
greater tuberosity osteopenia and the chronicity of rotator cuff tears. Journal of 404 
shoulder and elbow surgery / American Shoulder and Elbow Surgeons ... [et al.] 2008; 405 
17:73-7. 10.1016/j.jse.2007.04.017. 406 
4. Carpenter JE, Thomopoulos S, Flanagan CL, DeBano CM, Soslowsky LJ. Rotator 407 
cuff defect healing: a biomechanical and histologic analysis in an animal model. 408 
Journal of shoulder and elbow surgery / American Shoulder and Elbow Surgeons ... 409 
[et al.] 1998; 7:599-605. 410 
5. Greis PE, Burks RT, Bachus K, Luker MG. The influence of tendon length and fit 411 
on the strength of a tendon-bone tunnel complex. A biomechanical and histologic 412 
study in the dog. The American journal of sports medicine 2001; 29:493-7. 413 
6. Gulotta LV, Kovacevic D, Ehteshami JR, Dagher E, Packer JD, Rodeo SA. 414 
Application of bone marrow-derived mesenchymal stem cells in a rotator cuff repair 415 
Tendon Reattachment using Demineralised Bone Matrix 
 22 
model. The American journal of sports medicine 2009; 37:2126-33. 416 
10.1177/0363546509339582. 417 
7. Harryman DT, 2nd, Mack LA, Wang KY, Jackins SE, Richardson ML, Matsen FA, 418 
3rd. Repairs of the rotator cuff. Correlation of functional results with integrity of the 419 
cuff. The Journal of bone and joint surgery. American volume 1991; 73:982-9. 420 
8. Ide J, Kikukawa K, Hirose J, Iyama K, Sakamoto H, Mizuta H. Reconstruction of 421 
large rotator-cuff tears with acellular dermal matrix grafts in rats. Journal of shoulder 422 
and elbow surgery / American Shoulder and Elbow Surgeons ... [et al.] 2009; 18:288-423 
95. 10.1016/j.jse.2008.09.004. 424 
9. Kilicoglu OI. Effects of demineralized bone matrix on tendon-bone healing: an in 425 
vivo, experimental study on rabbits. Acta orthopaedica et traumatologica turcica 426 
2012; 46:443-48. 10.3944/aott.2012.2748. 427 
10. Liu SH, Baker CL. Arthroscopically assisted rotator cuff repair: correlation of 428 
functional results with integrity of the cuff. Arthroscopy : the journal of arthroscopic 429 
& related surgery : official publication of the Arthroscopy Association of North 430 
America and the International Arthroscopy Association 1994; 10:54-60. 431 
11. Longo UG, Franceschi F, Ruzzini L, Rabitti C, Morini S, Maffulli N et al. 432 
Histopathology of the supraspinatus tendon in rotator cuff tears. The American 433 
journal of sports medicine 2008; 36:533-8. 10.1177/0363546507308549. 434 
12. Lovric V, Chen D, Yu Y, Oliver RA, Genin F, Walsh WR. Effects of 435 
demineralized bone matrix on tendon-bone healing in an intra-articular rodent model. 436 
The American journal of sports medicine 2012; 40:2365-74. 437 
10.1177/0363546512457648. 438 
Tendon Reattachment using Demineralised Bone Matrix 
 23 
13. Movin T, Gad A, Reinholt FP, Rolf C. Tendon pathology in long-standing 439 
achillodynia. Biopsy findings in 40 patients. Acta orthopaedica Scandinavica 1997; 440 
68:170-5. 441 
14. Nho SJ, Yadav H, Shindle MK, Macgillivray JD. Rotator cuff degeneration: 442 
etiology and pathogenesis. The American journal of sports medicine 2008; 36:987-93. 443 
10.1177/0363546508317344. 444 
15. Postl LK, Braunstein V, von Eisenhart-Rothe R, Kirchhoff C. Footprint 445 
reconstruction in a rotator cuff tear associated cyst of the greater tuberosity: 446 
augmented anchorage. Archives of orthopaedic and trauma surgery 2013; 133:81-5. 447 
10.1007/s00402-012-1620-6. 448 
16. Sundar S, Pendegrass CJ, Blunn GW. Tendon bone healing can be enhanced by 449 
demineralized bone matrix: a functional and histological study. Journal of biomedical 450 
materials research. Part B, Applied biomaterials 2009; 88:115-22. 451 
10.1002/jbm.b.31157. 452 
17. Thangarajah T, Shahbazi S, Pendegrass CJ, Lambert S, Alexander S, Blunn GW. 453 
Tendon Reattachment to Bone in an Ovine Tendon Defect Model of Retraction Using 454 
Allogenic and Xenogenic Demineralised Bone Matrix Incorporated with 455 
Mesenchymal Stem Cells. PloS one 2016; 11:e0161473. 456 
10.1371/journal.pone.0161473. 457 
18. Thomopoulos S, Genin GM, Galatz LM. The development and morphogenesis of 458 
the tendon-to-bone insertion - what development can teach us about healing. Journal 459 
of musculoskeletal & neuronal interactions 2010; 10:35-45. No doi.  460 
19. Thomopoulos S, Hattersley G, Rosen V, Mertens M, Galatz L, Williams GR et al. 461 
The localized expression of extracellular matrix components in healing tendon 462 
insertion sites: an in situ hybridization study. Journal of orthopaedic research : official 463 
Tendon Reattachment using Demineralised Bone Matrix 
 24 
publication of the Orthopaedic Research Society 2002; 20:454-63. 10.1016/s0736-464 
0266(01)00144-9. 465 
20. Urist MR. Bone: formation by autoinduction. Science 1965; 150:893-9. 466 
21. Waldorff EI, Lindner J, Kijek TG, Downie BK, Hughes RE, Carpenter JE et al. 467 
Bone density of the greater tuberosity is decreased in rotator cuff disease with and 468 
without full-thickness tears. Journal of shoulder and elbow surgery / American 469 
Shoulder and Elbow Surgeons ... [et al.] 2011; 20:904-8. 10.1016/j.jse.2010.12.009. 470 
471 
Tendon Reattachment using Demineralised Bone Matrix 
 25 
FIGURE AND TABLE LEGENDS  472 
  473 
Figure 1: Supraspinatus tendon-bone fixation.  474 
 475 
Figure 2: Supraspinatus tendon-bone fixation, post-mortem, with cortical DBM (A), 476 
GraftJacket (B), and direct repair of tendon to bone (Control) (C).   477 
 478 
Figure 3: Photomicrograph of the enthesis at six weeks. Specimens stained with H&E. 479 
(a) Control: Direct tendon-bone repair characterized by a graded enthesis comprising 480 
tendon (T), fibrocartilage (FC), mineralised fibrocartilage, and bone (B). (b) DBM: 481 
DBM neo enthesis comprising a well organised, graded enthesis. (c) GraftJacket: 482 
GraftJacket neo enthesis with a disorganized structure.  483 
 484 
Figure 4: Box and whiskers plot illustrating the enthesis maturation scores following 485 
tendon reattachment using no augmentation strategy (controls), DBM, and 486 
GraftJacket. 487 
  488 
Figure 5: Box and whiskers plot illustrating the modified Movin scores following 489 
tendon reattachment using no augmentation strategy (controls), DBM, and 490 
GraftJacket.  491 
  492 
Figure 6: Photomicrograph (under polarized light) showing collagen fiber structure. 493 
(a) Controls (direct tendon-bone repair). (b) DBM group. (c) GraftJacket group.    494 
 495 
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Figure 7: Photomicrograph illustrating rounded nuclei in control (direct tendon-bone 496 
repair) (a), DBM (b), and GraftJacket (c).  497 
  498 
Figure 8: Box and whiskers plot showing total bone mineral density at the 499 
supraspinatus tendon-bone insertion 6 weeks following direct tendon to bone repair, 500 
repair with cortical DBM, and repair with GraftJacket. 501 
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